1.00 / AMA PRA Category 1 CreditTM 1.00 / ANCC Contact Hour
Provided by Horizon CME
This session is supported by an independent educational grant provided by Quest Diagnostics.
This activity reviews the role of the antinuclear antibody (ANA) test and subserology tests for facilitating a timely diagnosis of autoimmune diseases in patients with clinical suspicion of disease or to rule out other conditions with similar signs and symptoms. The advantages and disadvantages of ANA testing methods will be reviewed as will the roles of various subserology tests such as the use of rheumatoid factor (RF), anti-CCP antibody, and 14-3-3η protein in the diagnosis of rheumatoid arthritis. The webcast offers a unique opportunity for learners to immerse themselves in a case-based discussion and access the insights of expert faculty to aid them in engaging patients in conversations about the appropriateness of various medical tests and procedures as is being championed by the ABIM Foundation's “Choosing Wisely” initiative.
Primary care providers, including MDs/DOs, NPs, PAs, and other healthcare professionals who manage patients with autoimmune disorders
At the conclusion of this activity, participants should be better able to:
Discuss the importance and role of ANA testing for timely diagnosis of autoimmune disorders in primary care
Compare and contrast ANA testing methods
Implement strategies for choosing wisely and appropriately regarding ANA and subserology antibody testing
Assess the utility of rheumatoid factor (RF), anti-CCP antibody, and 14-3-3η protein for the diagnosis of rheumatoid arthritis
Conflict Of Interest Disclosure Policy
Horizon CME requires instructors, planners, managers and other individuals who are in a position to influence the content of this activity to disclose any real or apparent conflict of interest (COI) which may arise as a result of prospective faculty members’ relevant relationships with drug or device manufacturer(s). Horizon CME is committed to resolving all conflicts of interest and retaining only those speakers with financial interest conflicts that can be reconciled with the goals and educational integrity of the CME activity.
Anne R. Bass, MD Professor of Clinical Medicine Weill Cornell Medicine Attending Physician Hospital for Special Surgery New York, NY
Dr. Bass discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months.
Mary Lindholm, MD Associate Professor Department of Family Medicine and Community Health University of Massachusetts Medical School Worcester, MA
Dr. Lindholm discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months.
Non-faculty Contributors/Planners Non-faculty contributors and others involved in the planning, development, and editing/review of the content disclose no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months.
AMA PRA Category 1 Credit(s)TM
Horizon CME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Horizon CME designates this activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Contact Hour(s)
This continuing nursing education activity was approved by Oregon Nurses
Association, an accredited approver by the American Nurses Credentialing
Center's Commission on Accreditation. Approval valid through 6/20/2021.
OCEAN ID #2019-33.
This activity has received OCEAN approval for 1.00 contact hour.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CME credit for participation, participants must complete the posttest (achieving a passing grade of 75% or greater) and program evaluation. Certificates can be printed immediately.
For questions regarding CME credit, please contact Katie Oakes at Horizon CME (503) 659-5558.